Aditxt, Inc. (ADTX)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
---|---|---|---|---|
Sales | 1,004 | 1,018 | 6,854 | 44,276 |
Cost of goods sold | 1,005 | 734 | 467,536 | 23,134 |
Gross profit (loss) | -1 | 284 | -460,682 | 21,142 |
Sales and marketing 473,311, 0, 473,311, and 0 in stock-based compensation, respectively | 349,031 | 50,920 | 30,000 | 24,218 |
Research and development 0, 1,000,000, 10,000 and 6,712,663 in stock-based compensation, respectively | 764,327 | 1,209,205 | 491,552 | 1,553,360 |
General and administrative expenses 0, 4,097, 0, and 381,471 in stock-based compensation, respectively | 5,039,036 | 4,348,274 | 3,718,804 | 4,419,545 |
Total operating expenses | 6,152,394 | 5,608,399 | 4,240,356 | 5,997,123 |
Net loss from operations | -6,152,395 | -5,608,115 | -4,701,038 | -5,975,981 |
Interest income, other | - | - | - | 378 |
Interest expense, debt, excluding amortization | - | - | - | 1,091,568 |
Interest income | 78,566 | 288 | 376 | - |
Interest expense | 47,352 | 157,499 | 570,114 | - |
Change in fair value of derivative liability | -980 | -13,145 | - | - |
Amortization of debt discount | 1,212,246 | 200,284 | 1,709,537 | 556,708 |
Gain (loss) on note exchange agreement | - | - | - | - |
Change in fair value of evofem warrants | 63,211 | - | - | - |
Total other expense | -1,243,263 | -344,350 | -2,279,275 | -1,647,898 |
Net loss before income taxes | -7,395,658 | -5,952,465 | -6,980,313 | -7,623,879 |
Income tax provision | - | - | - | - |
Net loss | -7,395,658 | -5,952,465 | -6,980,313 | -7,623,879 |
Net loss attributable to non-controlling interest | -138,850 | -242,156 | -39,801 | -74,260 |
Implied dividends | - | - | -5,907,011 | - |
Net loss attributable to aditxt, inc. & subsidiaries | -7,256,808 | -5,710,309 | -12,847,523 | -7,549,619 |
Net loss per share - diluted (in dollars per share) | -3.45 | -8.12 | -111.07 | -4.19 |
Net loss per share, basic (in dollars per share) | -3.45 | -8.12 | -111.07 | -4.19 |
Weighted average number of shares outstanding during the period - diluted (in shares) | 2,101,701 | 703,666 | 115,672 | 1,802,379 |
Weighted average number of shares outstanding during the period, basic (in shares) | 2,101,701 | 703,666 | 115,672 | 1,802,379 |